Yarrow Bioscience, Inc. YARW

About Yarrow Bioscience, Inc. (YARW): stock profile, AI score and financials

Yarrow Bioscience, Inc. (YARW) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores YARW at 19.6/100 on a composite quality score built from its SEC filings, placing it at rank #2,757 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Yarrow Bioscience, Inc. reports quarterly revenue of $97.0K, net income of $-3.0M. Top institutional holders of YARW by reported 13-F value include ADAR1 Capital Management, Nantahala Capital Management, Lynx1 Capital Management, based on the most recent SEC filings. YARW trades on the Nasdaq exchange and files with the SEC under CIK 1566044. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate YARW daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Yarrow Bioscience, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1566044 →